Expression Analysis Announces Additions to its Scientific Advisory Board.DURHAM, N.C. -- Expression Analysis, Inc., a full-service microarray testing, analysis and data management organization, has announced additions to its scientific advisory board. John Ryan John Ryan can refer to:
"Our current Scientific Advisory Board members are thought leaders in genomic technologies and genomic medicine," said Steve McPhail, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Expression Analysis, Inc. "Our new Scientific Advisory Board members nicely compliment our current members with additional experience in both the pharmaceutical and clinical diagnostic industries. We believe that the new makeup of our Scientific Advisory Board will assist our company in our vision of bridging the use of microarray-based pharmacogenomic assays in clinical trials to targeted molecular diagnostics." John L. Ryan, Ph.D., M.D., is Chief Medical Officer for AVEO Pharmaceuticals, Cambridge, MA. He is responsible for clinical strategy and development of AVEO's pipeline. Dr. Ryan brings almost 20 years of experience in drug discovery and development, including expertise in translational medicine translational medicine Molecular medicine The constellation of activities which seek to translate the science of gene discovery, gene transfer, and functional genomics into gene-targeted therapies and cancer biology. Prior to AVEO, Dr. Ryan spent 11 years at Wyeth where he most recently held the position of Senior Vice President of Translational Research and Head of the Department of Experimental Medicine, which was created to explore new technologies such as pharmacogenomics in exploratory clinical trials, and to work closely with FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. on the use of transcriptional profiling in clinical trials. Prior to Wyeth, Dr, Ryan held positions in Clinical Research and Development at Genetics Institute and Merck Research Laboratories. Dr. Ryan received his BS, MS and Ph.D. degrees from Yale University and his M.D. from the University of California, San Diego UCSD is consistently ranked among the top ten public universities for undergraduate education in the United States by U.S. News & World Report.[3] It is a Public Ivy. [1] For graduate studies, most of UCSD's Ph.D. . He was a member of the Department of Internal Medicine at Yale, prior to joining Merck. Dr. Richard D. Hockett's current position is Director of Genomic Medicine at Eli Lilly and Company Eli Lilly and Company (NYSE: LLY) is a global pharmaceutical company and one of the world's largest corporations. Eli Lilly's global headquarters is located in Indianapolis, Indiana, in the United States. , Indianapolis in the Department of Diagnostic and Experimental Medicine. His responsibilities include applied genomics applied genomics Molecular genetics Molecular medicine The use of genetic information to diagnose, prognosticate and manage disease, based on the techniques of PCR, real time-PCR, DNA sequencing, and gene rearrangement studies for leukemia and lymphoma. and biomarker development. Special areas of focus are molecular diagnostics, specimen banking, and immunology. Prior to joining Lilly, Dr. Hockett was at the University of Alabama at Birmingham UAB began in 1936 as the Birmingham Extension Center of the University of Alabama. Because of the rapid growth of the Birmingham area, it was decided that an extension program for students who had difficulties which prevented them from studying in Tuscaloosa was needed. , Department of Pathology, where he oversaw the Clinical Immunology and Molecular Diagnostic Laboratories. His research interests have been in the areas of Developmental Immunology and HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. disease. Dr. Hockett received his M.D. degree from the University of Minnesota (body, education) University of Minnesota - The home of Gopher. http://umn.edu/. Address: Minneapolis, Minnesota, USA. , and did his residency in Clinical Pathology clinical pathology n. 1. The practice of pathology as it pertains to the care of patients. 2. The subspecialty in pathology concerned with the theoretical and technical aspects of laboratory technology that pertain to the at Washington University, St. Louis. Mr. Buzz Sztukowski is currently Sr. Vice President for Global Marketing and Strategic Development with bioMerieux of Lyons, France, a billion dollar global diagnostics company. Mr. Sztukowski is responsible for product development as well as global business and marketing strategies for the company's Microbiology Business. He joined bioMerieux in 1998 as Sr. Vice President of NA Commercial Operations before moving into his current role in 2002. Prior to joining bioMerieux Mr. Sztukowski was President of Remel, Inc. a manufacturer and distributor of microbiology products. His experience includes thirteen years with Abbott Laboratories Diagnostic Division, where he held a series of positions with increasing responsibilities in sales and marketing management including worldwide marketing. Joseph R. Nevins PhD, Chair of the Board, and the Barbara Levine University Professor of Breast Cancer Genomics and Director of the Center for Applied Genomics and Technology at Duke University, Geoffrey Ginsburg, MD, PhD, Professor of Medicine and Director of the Center for Genomic Medicine at Duke University and Mike West, Ph. D., Professor of Biostatistics & Bioinformatics, Arts & Sciences Professor of Statistics and Decision Sciences at Duke University will continue their service on the Expression Analysis Scientific Advisory Board. About Expression Analysis Expression Analysis, Inc., (EA) (www.expressionanalysis.com) is a full-service microarray genetics testing and analysis organization dedicated to providing clients with the highest quality genomic processing and data analysis services using Affymetrix GeneChip(R) brand technology. EA is one of the few U.S.-based authorized service providers for Affymetrix (www.affymetrix.com), a California-based company that develops and commercializes systems to help researchers explore the relationship between genes and human health. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion